The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19ACTIV-3/TICO Study Group, Angela J. Rogers, Deborah Wentworth et al.|Annals of Internal Medicine|2022Cited by 63
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to RemdesivirKanal Singh, Jason W. Van Winkle, Sylvain Laverdure et al.|The Journal of Infectious Diseases|2024Cited by 13
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19Tomas Ø. Jensen, Mark D. Miller, Greg Grandits et al.|The Journal of Infectious Diseases|2023Cited by 4